publication . Article . 2008

The effects of prior calcium channel blocker therapy on creatine kinase-MB levels after percutaneous coronary interventions.

Gulmez, Oyku; Atar, Ilyas; Ozin, Bülent; Korkmaz, Mehmet Emin; Atar, Asli; Aydinalp, Alp; Yildirir, Aylin; Muderrisoglu, Haldun;
Open Access
  • Published: 01 Dec 2008 Journal: Vascular Health and Risk Management, volume Volume 4, pages 1,417-1,422 (eissn: 1178-2048, Copyright policy)
  • Publisher: Dove Medical Press Ltd.
Abstract
Oyku Gulmez, Ilyas Atar, Bülent Ozin, Mehmet Emin Korkmaz, Aslı Atar, Alp Aydinalp, Aylin Yildirir, Haldun MuderrisogluBaskent University Faculty of Medicine, Department of Cardiology, Ankara, TurkeyBackground: Use of intracoronary calcium channel blockers (CCBs) during percutaneous coronary intervention (PCI) has been shown to have favorable effects on coronary blood flow. We aimed to investigate the effects of CCBs administrated perorally on creatine kinase-MB (CK-MB) levels in patients undergoing elective PCI.Methods: A total of 570 patients who underwent PCI were evaluated for CK-MB elevation. Patients who were on CCB therapy when admitted to the h...
Subjects
free text keywords: Vascular Health and Risk Management, Internal medicine, medicine.medical_specialty, medicine, business.industry, business, Diabetes mellitus, medicine.disease, Conventional PCI, Coronary artery disease, Blood flow, Calcium channel, Creatine, chemistry.chemical_compound, chemistry, Percutaneous, Percutaneous coronary intervention, medicine.medical_treatment, Cardiology, Original Research, calcium channel blockers, myonecrosis, percutaneous coronary interventions, Diseases of the circulatory (Cardiovascular) system, RC666-701
30 references, page 1 of 2

Abdelmeguid AE, Topol EJ, Whitlow PL, et al. 1996. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation, 94:1528-36. [OpenAIRE]

Abdelmeguid AE, Topol EJ. 1996. The myth of the myocardial 'infarctlet' during percutaneous coronary revascularization procedures. Circulation, 94:3369-75. [OpenAIRE]

Akkerhuis KM, Alexander JH, Tardiff BE, et al. 2002. Minor myocardial damage and prognosis. Circulation, 105:554-6. [OpenAIRE]

Aronow HD, McRae T, Quinn MJ. 2002b. Patients on lipid-lowering therapy at the time of myocardial infarction have smaller infarcts: further evidence to suggest a salutary effect in acute coronary syndrome [abstract]. J Am Coll Cardiol, 39:318A. [OpenAIRE]

Aronow HD, Quinn MJ, Gurm HS. 2002a. Myocardial necrosis is halved in patients undergoing elective percutaneous coronary intervention who are pretreated with lipid-lowering therapy [abstract]. J Am Coll Cardiol, 39:32A. [OpenAIRE]

Bestehorn HP, Neumann FJ, Büttner HJ, et al. 2004. Evaluation of the oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention. The randomized, double-blind, placebo-controlled, multicenter verapamil slow-release for prevention of cardiovascular events after angioplasty (VESPA) trial. J Am Coll Cardiol, 43:2160-5. [OpenAIRE]

Califf RM, Abdelmeguid AE, Kuntz RE, et al. 1998. Myonecrosis after revascularization procedures. J Am Coll Cardiol, 31:241-51. [OpenAIRE]

Demir I, Yılmaz H, Ermi¸s C, et al. 2002. Treatment of no re-flow phenomenon with verapamil after primary stent deployment during myocardial infarction. Jpn Heart J, 43:573-80.

Dens J, Desmet W, Piessens J. 2003. An updated meta-analysis of calcium-channel blockers in the prevention of restenosis after coronary angioplasty. Am Heart J, 145:404-8.

Desmet WJ, Dens J, Coussement P, et al. 2002. Does adenosine prevent myocardial micronecrosis following percutaneous coronary intervention? The ADELINE pilot trial. ADEnosine Limit myocardial Necrosis. Heart, 88:293-5. [OpenAIRE]

Ellis S, Sorin JB, Lincoff AM, et al. 2001. Beta-blockers before percutaneous coronary intervention do not attenuate postprocedural creatine kinase isoenzyme rise. Circulation, 104:2685-8. [OpenAIRE]

[ENCORE] The ENCORE Investigators. 2003. Effect of nifedipine and cerivastatin on coronary endothelial function in patients with coronary artery disease: the ENCORE I Study (Evaluation of Nifedipine and Cerivastatin in Recovery of coronary Endothelial function). Circulation, 107:422-8.

[EPISTENT] The EPISTENT Investigators. 1998. Randomized placebocontrolled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet, 352:87-92.

Folts JD. 1997. Inhibition of platelet activity in vivo by amlodipine alone and combined with aspirin. Int J Cardiol, 62: S111-7.

Herrmann J, Lerman A, Baumgart D, et al. 2002. Preprocedural statin medication reduces the extent of per procedural non-Q-wave myocardial infarction. Circulation, 106:2180-3.

30 references, page 1 of 2
Powered by OpenAIRE Open Research Graph
Any information missing or wrong?Report an Issue
publication . Article . 2008

The effects of prior calcium channel blocker therapy on creatine kinase-MB levels after percutaneous coronary interventions.

Gulmez, Oyku; Atar, Ilyas; Ozin, Bülent; Korkmaz, Mehmet Emin; Atar, Asli; Aydinalp, Alp; Yildirir, Aylin; Muderrisoglu, Haldun;